
For
immediate release -- Friday, October 13, 2000.
Contact
Bob Brammer - 515-281-6699 |
|
Miller:
Change Iowa Law to Increase Anti-Trust Recoveries
Iowa
will receive part of a huge settlement in a vitamin price-fixing case -but
Iowa's share is only $45,000 of the $255 million settlement, Miller says.
DES MOINES-- Attorney General Tom Miller said today that
Iowa is receiving $45,000 in settlement of a case alleging that the world's
largest vitamin companies conspired to fix prices for a decade - but Miller
says Iowa law should be changed to enable much larger recoveries in such
anti-trust cases.
"The good news is
that Iowa will receive $45,000. We are one of 47 states to share recovery
of $3 million in overcharges paid directly by states to the vitamin companies
as a result of the price-fixing," Miller said. "The bad news is that Iowa
cannot claim a share of about $250 million going to states for overcharges
paid by the states indirectly or paid by their consumers,"
he said.
"We need to change
Iowa law, as many other states have, to enable us to recover overcharges
when the state or a consumer is directly or indirectly harmed by price-fixing
or anti-competitive conduct," he said.
Miller estimated Iowa
would have recovered between $3 million and $4 million if Iowa law permitted
recovery for indirect purchases as well as direct purchases. Miller's
Office has proposed the change in the past and will do so again to the
next General Assembly, he said.
The International
Vitamin Price-Fixing Case
The States worked
together to recover overcharges resulting from price-fixing by the world's
largest vitamin makers - three pharmaceutical companies from Europe and
three from Japan. The companies produce vitamin pills, and vitamin blends
and supplements used extensively in agricultural feed and in fortified
foods ranging from milk and bread to beverages, cereal and peanut butter.
The companies controlled more than 80% of the world's vitamin market.
According to the U.S.
Justice Department, the companies organized an elaborate system to divide
up markets and fix prices from 1990 to 1999. The price-fixing included
secret meetings, allocating markets for sales, and trying to hide the
conspiracy by burning papers that might document the illegal collusion.
The companies paid record-high criminal fines of $750 million last year
as a result of the U.S. Justice Department's criminal case, and they also
agreed to pay over $1 billion to companies that directly purchased bulk
vitamins from them.
The settlement reached
Monday with the States totals about $255 million. About $225 million goes
to 21 states for higher costs to consumers and businesses as a result
of the price-fixing. Iowa is not among those states. About $30 million
goes to States in compensation for higher charges the states themselves
paid for vitamin products.
Of the $30 million,
about $3 million will be divided among 47 states - including Iowa -- for
overcharges paid directly by the states -- for example, for vitamin
pills bought by state institutions. The remaining $27 million will be
shared by states that have authority to seek recovery of indirect payment
overcharges - not including Iowa. Iowa law does not provide for recovering
overcharges paid indirectly by the state - for example, for institution
food whose price was inflated by price-fixing in vitamin supplements in
the food.
"We need to be able
to go after price-fixing overcharges for the State of Iowa's indirect
purchases, and for overcharges paid by Iowa consumers and businesses,"
Miller said. "Many states have this authority, and we will once again
make this important proposal to the Legislature for the upcoming session.
It can mean millions of dollars to Iowa in this kind of case, and there
certainly will be more cases like this in the future."
The States' settlement
was filed Tuesday in Federal District Court in Washington D.C. Defendants
in the case are three European companies, F. Hoffman-La Roche of Switzerland,
BASF of Germany, and Aventis of France; and three Japanese companies,
Takeda Chemical Industries Ltd., Eisai Co. Ltd, and Daiichi Pharmaceutical
Co. Ltd. The companies also agreed to an injunction prohibiting them from
engaging in this type of illegal behavior.
- 30
-
|